1. Home
  2. BON vs ALZN Comparison

BON vs ALZN Comparison

Compare BON & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bon Natural Life Limited

BON

Bon Natural Life Limited

N/A

Current Price

$1.22

Market Cap

8.7M

Sector

Health Care

ML Signal

N/A

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

N/A

Current Price

$1.73

Market Cap

7.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BON
ALZN
Founded
2006
2016
Country
China
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
7.5M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
BON
ALZN
Price
$1.22
$1.73
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $28.00
AVG Volume (30 Days)
7.0K
★ 99.5K
Earning Date
01-23-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 76.77
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$390.73
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$0.84
52 Week High
$2.34
$2.68

Technical Indicators

Market Signals
Indicator
BON
ALZN
Relative Strength Index (RSI) 57.73 62.26
Support Level $1.14 $1.69
Resistance Level $1.22 $2.22
Average True Range (ATR) 0.06 0.09
MACD 0.01 -0.01
Stochastic Oscillator 87.82 70.61

Price Performance

Historical Comparison
BON
ALZN

About BON Bon Natural Life Limited

Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.

Share on Social Networks: